Hence, there is a critical need to enhance our understanding through pharmacological management, which unfortunately remains limited
Use in patients undergoing obesity-related weight loss treatment , including GLP-1 receptor agonists, dual agonists targeting GLP-1, GIP, and/or glucagon pathways, and triple agonists targeting GLP-1, GIP, and glucagon pathways
In studies with rodents, tirzepatide caused thyroid tumors, including thyroid cancer
NAIC staff supports these efforts and represents the collective views of state regulators domestically and internationally.
"With GLP-1 usage, the biggest change to restaurants won't be that consumers stop going out to eat, it will be how they go out to eat and what they order," David Portalatin, senior vice president at Circana, said in a statement
Conversely, others experience the most intense side effects within the first 24 hours, preferring to sleep through the initial impact